Vaccine that makes jabs obsolete
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.VACCINATIONS of the future could consist of having a liquid rubbed into your skin, rather than the pain of a needle prick - and all because of cholera.
US army scientists have discovered that the toxin produced by the cholera bacterium stimulates an immune response even when it is put on the skin, and that it speeds up immune responses to any other foreign protein added to it.
Tests on laboratory mice have confirmed cholera's effectiveness in helping the body to generate antibodies to diphtheria and tetanus.
Trials on humans are due to start at the end of next month. If all goes well the needle-free system could be available commercially within the next five to 10 years.
"We can take an off-the- shelf vaccine, mix it with cholera toxin and get a very nice immune response from that off-the-shelf type vaccine," said Dr Gregory Glenn, of the department of biochemistry at the Walter Reed Army Institute of Research, in Washington DC.
"The implications are that one could eliminate needles."
The army scientists' work is reported today in the science journal Nature.
The method could revolutionise vaccination programmes in developing countries, where the cost of needles for injections can be prohibitive.
The idea of using a potentially dangerous disease to produce medical benefits - the basis of immunisation - is also being suggested for techniques such as gene therapy.
Some scientists have suggested using a weakened form of HIV, the virus that causes Aids, to carry out gene therapy for genetic diseases such as cystic fibrosis.
Because HIV adds its own genetic material to the host, it could act as the carrier for helpful genes - such as those to cure cystic fibrosis. However, that work is still in its early stages.
Cholera is a more promising candidate for pain-free immunisation. Though widely feared as a disease, its real danger lies in its dehydrating effects.
When consumed (usually through infected water), the bacteria produce a toxin which inflames the gut and leads to diarrhoea and vomiting. The rapid fluid loss can seriously weaken the body. But if the lost fluids are replaced from uncontaminated sources, the immune system can usually overcome the infection.
In that sense, the cholera toxin is not deadly - instead, the principal risk arises from its side-effects.
Thus it makes an ideal candidate as an "adjuvant" for helping provoke an immune response.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments